Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Insulet Corp. | 14 | 0 | 1 | 0 | €159.80 | €215.54 | 34.879% |
| Integer Hldg | 1 | 0 | 0 | 0 | €104.00 | - | - |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | €11.84 | €22.78 | 92.440% |
| LivaNova plc | 8 | 0 | 2 | 0 | €51.50 | €65.63 | 27.429% |
| Masimo Corp. | 7 | 1 | 2 | 0 | €126.15 | €147.62 | 17.016% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €372.10 | €421.61 | 13.304% |
| Merit Medical Systems | 16 | 0 | 5 | 0 | €69.50 | €86.90 | 25.032% |
| Molina Healthcare | 12 | 1 | 2 | 0 | €317.40 | €366.73 | 15.541% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €66.10 | €65.00 | -1.664% |
| Myriad Genetics | 5 | 2 | 0 | 0 | €18.30 | €23.22 | 26.872% |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | €1.49 | €3.70 | 147.657% |
| Neurocrine Bioscience | 23 | 0 | 3 | 0 | €134.35 | €137.63 | 2.444% |
| Perrigo Co. plc | 3 | 0 | 1 | 0 | €30.77 | €35.99 | 16.949% |
| PTC Therapeutics Inc. | 13 | 6 | 2 | 1 | €29.80 | €41.51 | 39.304% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Repligen Corp. | 12 | 0 | 0 | 0 | €148.70 | €182.96 | 23.040% |
| Sartorius AG VZO | 4 | 0 | 0 | 0 | €283.10 | - | - |
| Select Medical Holdings | 3 | 0 | 1 | 0 | €26.00 | €36.41 | 40.025% |
| Taro Pharmaceutical Industries Ltd | 7 | 0 | 1 | 0 | €39.40 | - | - |
| Tenet Healthcare | 27 | 0 | 6 | 0 | €109.00 | €101.06 | -7.280% |
| Ultragenyx Pharmaceutical Inc. | 16 | 1 | 3 | 0 | €41.20 | €82.93 | 101.289% |
| United Therapeutics | 15 | 0 | 0 | 0 | €239.20 | €289.92 | 21.204% |
| Viatris Inc. | 1 | 0 | 0 | 0 | €10.99 | - | - |
| West Pharmaceutical Services Inc. | 6 | 0 | 0 | 0 | €341.80 | €369.72 | 8.170% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €18.70 | €31.74 | 69.727% |